Konstantinos Xynos
CIK: 0001956241
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Replimune Group, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 10, 2026REPL
Replimune Group, Inc.
Sale(S)Direct11.4K shares at avg. $12.97$148K - May 18, 2026REPL
Replimune Group, Inc.
Sale(S)Direct14K shares at avg. $5.08$71K - Apr 1, 2026REPL
Replimune Group, Inc.
Award(A)Direct50K shares- - Dec 19, 2025REPL
Replimune Group, Inc.
Award(A)Direct60K shares- - Nov 17, 2025REPL
Replimune Group, Inc.
Sale(S)Direct7.2K shares at avg. $9.10$66K - May 20, 2025REPL
Replimune Group, Inc.
Sale(S)Direct8K shares at avg. $8.06$64K - Apr 1, 2025REPL
Replimune Group, Inc.
Award(A)Direct45K shares- - Nov 18, 2024REPL
Replimune Group, Inc.
Sale(S)Direct7.2K shares at avg. $10.78$78K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | REPL Replimune Group, Inc. | Sale(S) | 11,447 | $12.97 | $148,468 | Direct |
| May 18, 2026 | REPL Replimune Group, Inc. | Sale(S) | 14,023 | $5.08 | $71,237 | Direct |
| Apr 1, 2026 | REPL Replimune Group, Inc. | Award(A) | 50,000 | - | $0 | Direct |
| Dec 19, 2025 | REPL Replimune Group, Inc. | Award(A) | 60,000 | - | - | Direct |
| Nov 17, 2025 | REPL Replimune Group, Inc. | Sale(S) | 7,248 | $9.10 | $65,957 | Direct |
| May 20, 2025 | REPL Replimune Group, Inc. | Sale(S) | 7,952 | $8.06 | $64,093 | Direct |
| Apr 1, 2025 | REPL Replimune Group, Inc. | Award(A) | 45,000 | - | - | Direct |
| Nov 18, 2024 | REPL Replimune Group, Inc. | Sale(S) | 7,246 | $10.78 | $78,112 | Direct |
1-8 of 8 transactions
About Xynos Konstantinos
Xynos Konstantinos (SEC CIK 0001956241) files insider reports with the SEC as Chief Medical Officer of Replimune Group, Inc. (REPL).
Signal8 holds 8 ownership filings by Xynos Konstantinos, all Form 4s, filed between Nov 20, 2024 and Aug 12, 2026. Those filings report 8 transactions, from Nov 18, 2024 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Xynos Konstantinos's filings is in WOBURN, MA.
Recent filings by Xynos Konstantinos
- Aug 10, 2026: Open-market sale of REPL shares (Form 4, code S).
- May 18, 2026: Open-market sale of REPL shares (Form 4, code S).
- Apr 1, 2026: Grant or award of REPL shares (Form 4, code A).
- Dec 19, 2025: Grant or award of REPL shares (Form 4, code A).
- Nov 17, 2025: Open-market sale of REPL shares (Form 4, code S).
Other insiders filing for Replimune Group, Inc. (REPL)
- Astley-Sparke Philip, Director
- Hill Emily Luisa, Chief Financial Officer
- Patel Sushil, Chief Executive Officer
- Schwendenman Andrew, Chief Accounting Officer
- BAKER BROS. ADVISORS LP, Director
- Sarchi Christopher, Chief Commercial Officer